跳至主要内容
临床试验/NCT04338386
NCT04338386尚未招募不适用

Detection and Pathogenesis of Novel Protein F

Wuhan Asia Heart Hospital0 个研究点目标入组 100 人开始时间: 2020年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
Concentration of plasma protein F content

研究概览

简要总结

From December 6, 2019 to March 23, 2020, the research group of Qingkun Fan found a novel protein(temporarily named protein F) in heparin anticoagulant plasma of three patients with heart disease. One patient was diagnosed with multiple myeloma.However, protein F cannot be detected by serum protein electrophoresis. Preliminary studies have shown that this novel protein F have an obvious absorption peak at about 600nm. Placed at 2-8 degrees for 7 days, protein F will be isolated from heparin plasma. To the naked eye, protein F appear to be transparent jelly between the red blood cells and the plasma. The specific protein F, how it is produced, how it causes disease are still unknown. This study will explore how to detect protein F and how it is produced.

详细描述

Protein F screening was performed on anticoagulant blood plasma with heparin Lithium or blood serum by in-house turbidimetric method in Automatic biochemical analyzer.

All patients were followed-up for 3 years by telephones, routine appointment out-patient clinic or returning visit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Testing total protein and albumin
  • Testing routine blood test

排除标准

  • high triglycerides (TG>5.00 mmol/L)
  • hyperbilirubinemia (TBIL>170 mmol/L)
  • fat emulsion used in past 3 days
  • patients with hemolytic disease
  • pregnant and lactating women

结局指标

主要结局

Concentration of plasma protein F content

时间窗: six month

the protein F content was measured by turbidimetric assay in automatic biochemical analyzer

次要结局

  • Number of Participants with Multiple myeloma(3 years)

研究者

申办方类型
Other
责任方
Sponsor

相似试验